Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cognitive Impairment in Multiple Sclerosis.
Purinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and death.
Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
How Natalizumab Binds and Antagonizes α4 Integrins.
Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study.
[Neuromyelitis optica.]
MR Imaging in Multiple Sclerosis: The Accuracy of 3D Double Inversion Recovery at 3 Tesla and the Potential for Single Sequence Imaging.
Cortico-juxtacortical involvement increases risk of epileptic seizures in multiple sclerosis.
The Impact of Social Media on Dissemination and Implementation of Clinical Practice Guidelines: A Longitudinal Observational Study.
Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore.
Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).
Selective depression of low-release probability excitatory synapses by sodium channel blockers.
The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures.
Picornavirus infection leading to immunosuppression.
The nervous system's potential role in multiple sclerosis associated bone loss.
Causes of diplopia in the emergency department: diagnostic accuracy of clinical assessment and of head computed tomography.
Seeing optic neuritis through myopic eyes.
Excitotoxic mechanisms of ischemic injury in myelinated white matter.
The effects of robot-assisted gait training in progressive multiple sclerosis: A randomized controlled trial.
Potentiation of High Voltage-Activated Calcium Channels by 4-Aminopyridine Depends upon Subunit Composition.
Non-local robust detection of DTI white matter differences with small databases.
Health-related quality of life in partners of persons with MS: a longitudinal 10-year perspective.
Placebo Cohorts in Phase-3 MS Treatment Trials - Predictors for On-Trial Disease Activity 1990-2010 Based on a Meta-Analysis and Individual Case Data.
Evaluation of the effectiveness of home based or hospital based calisthenic exercises in patients with multiple sclerosis.
Genetic characterization of gliomas arising in patients with multiple sclerosis.
Pages
« first
‹ previous
…
167
168
169
170
171
172
173
174
175
…
next ›
last »